An FDA advisory panel will review Grail's Galleri test
An FDA advisory panel will review Grail’s Galleri test. This was announced in an issue of STAT News’ biotech newsletter, The Readout. The article was published on August 10, 2026; its author is STAT News biotech correspondent Meghana Keshavan, who also contributes to The Readout.
In the same issue, STAT News announces an article on how the promise of precision in radiopharmaceuticals is running up against toxicity issues. Another topic covers the new regulations China is implementing in its biotechnology sector.
For more breaking news, follow the UA.News Telegram channel.
In a separate article, the publication describes these changes as tighter controls on clinical trials. Meanwhile, the U.S. is looking for ways to match the pace of biotechnology development in China. The Readout is a newsletter providing a morning roundup of science, politics, and finance news affecting the biotechnology sector.
